adefovir 中文意思是什麼

adefovir 解釋
阿德福韋
  1. The objective of this study was to assess the efficacy and safety of adefovir dipivoxil / adv ( hepsera ) therapy under compassionate use in patients with chronic hepatitis b ( chb ) and lamivudine resistance

    本文的目的就是研究阿德福偉在對拉米夫定耐藥的慢性乙肝患者當中使用的安全性和有效性。
  2. Some patients receiving adefovir dipivoxil ( hepsera ) at the approved dose of 10 mg daily for the treatment of chronic hepatitis b virus ( hbv ) infection have a suboptimal virological response characterized by a slow and moderate decrease in hbv replication

    有些接受阿德福韋核準每天10毫克藥量治療慢性乙肝感染的患者常出現緩慢，中度減低病毒復制的不佳抗病毒效應。
  3. Background & aims : adefovir monotherapy is an established treatment modality for lamivudine - experienced patients with chronic hepatitis b, but it carries a significant risk of resistance in the long term

    背景與目的：對于拉米夫定治療過的慢性乙肝患者，用阿德福韋酯單藥治療是一種明確的治療模式，但是從長遠觀點來看，這會帶來嚴重的耐藥風險。
  4. At that point, both groups were tested for hbv in their blood ; in the adefovir group, only 22 percent reached a target reduction in hbv 1000 copies ml versus nearly half 49 percent of the telbivudine group

    研究發現，在服用阿德?偉的組別，只有22 %的患者能夠減低乙型肝炎病毒達每毫升血液1000份病毒；相反，在替比夫定組別，則只有49 %能減低乙型肝炎病毒。
  5. New study demonstrates telbivudine s superiority to adefovir in hepatitis b treatment both newly diagnosed hepatitis b patients and those who have previously taken adefovir, a widely prescribed treatment for the disease, will see improved viral suppression with telbivudine, according to a new study presented at the asian pacific association for the study of liver apasl meeting in kyoto, japan

    亞太肝臟學會（ apasl ）在日本京都發表最新研究報告指出，無論是乙型肝炎新癥以及一些正在服用傳統藥物阿德?偉（ adefovir ）的乙型肝炎病人，在服用新一代的口服乙肝藥制劑替比夫定（ telbivudine ）后，可更有效抑制病毒復制，為乙型肝炎患者的新選擇。
  6. With this study, we have evidence that telbivudine is superior to adefovir in new patients, and we also have proof that in patients currently being sub - optimally treated with adefovir, telbivudine offers a better way to get the virus under control. the new data comes from a study of 135 patients with hepatitis b who were treated with either telbivudine or adefovir for 24 weeks

    今次研究更加進一步確定，無論是乙型肝炎新癥或現時正接受阿德?偉但未能有效控制乙型肝炎的病人，若服用替比夫定，對控制他們的病情更為有效，並且有助減少病毒數量，替比夫定的而且確為乙型肝炎患者帶來新希望。
  7. Of the 78 percent of adefovir patients who did not reach target viral suppression at 24 weeks, those who switched to telbivudine saw ten times greater incremental hbv suppression versus those patients who remained on adefovir for 52 weeks. telbivudine is a once - daily oral treatment for hepatitis b. telbivudine is already approved for use in 13 countries around the world, including australia, china, india, indonesia, korea, macau and the united states

    該78 %服用阿德?偉而在24個星期內抑制病毒復制未能達標的病人，研究人員再進行對照比較，部分病人轉用替比夫定，其餘則繼續服用阿德?偉，結果發現，轉服替比夫定藥物的患者，其抑制病毒復制的能力相比服用阿德?偉時提升了十倍。
  8. Determination of reference standard of adefovir dipivoxil by non - aqueous titration

    非水滴定法測定阿德福韋酯對照品含量
  9. The rate of hepatitis b virus resistance to adefovir dipivoxil and the evolution of hepatitis b virus in lamivudine - resistant chronic hepatitis b patients with adv monotherapy

    阿德福韋治療拉米夫定耐藥慢性乙型肝炎患者的耐藥率及耐藥株進化情況
  10. Prognosis of chronic hepatitis b has been improved significantly because of the clinical application of nucleoside / nucleotide analogues, such as lamivudine, adefovir dipivoxil, entecavir

    拉米夫定、阿德福韋酯和恩替卡韋等核苷/核苷酸類似物的臨床應用，大大改善了慢性乙型肝炎的預后。
  11. Examples of drugs in the class are lamivudine, entecavir and adefovir

    這類藥物的例子包括拉米夫定、恩替卡韋及阿德福韋。
  12. We assessed whether this risk could be overcome by adefovir - lamivudine combination therapy

    我們評估了阿德-拉米聯合治療能否克服這種風險。
  13. New study demonstrates telbivudine s superiority to adefovir in hepatitis b treatment

    新乙型肝炎藥物治療更見成效
  14. Improved synthesis of adefovir dipivoxil

    阿德福韋酯的合成工藝改進
  15. No amino acid substitutions known to confer adefovir resistance were detected in these patients

    沒有已知的，會造成阿德福韋抗藥氨基酸替代物質在這些患者中發現。
  16. However, they cautioned, " careful monitoring of renal function is necessary, " since adefovir is known to cause kidney toxicity at high doses

    但是，他們提醒， 「細心觀察腎臟功能是必需的， 「因為阿德福韋已知會在高劑量情況下造成腎臟毒性。
  17. Do not stop taking adefovir or change your dose without first talking to your doctor

    沒有問醫生之前不要停止治療或改變劑量。
分享友人
分享到 Line

分享到臉書